Your session is about to expire
← Back to Search
tDCS for Cognitive Enhancement (MINUTES Trial)
MINUTES Trial Summary
This trial will test transcranial direct current stimulation (tDCS) as a tool to improve cognition in healthy people and people with schizophrenia. tDCS sends a low current through the brain to stimulate or modulate neuronal activity. This study will test whether tDCS can increase cognitive abilities and whether these increases generalize to other domains.
MINUTES Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMINUTES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MINUTES Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can attend three 45-minute training sessions weekly for 12 weeks and go to four assessments.Ability to provide consent and comply with study procedures.No significant mental illness or addiction, as measured by the MINI, and no sleep disorder.Your IQ score should be between 70 and 115.I am between 18 and 60 years old.I have a condition or received treatment that affected my nervous system.
- Group 1: sham tDCS
- Group 2: right active-tDCS
- Group 3: left active-tDCS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial restrict participation to those over 85 years of age?
"This specific trial requires patients to be between 18 and 60 years of age. Additionally, there are 54 trials open for minors and 380 studies available for those above the retirement age."
How many participants are being monitored within this experiment?
"Affirmative. According to the information on clinicaltrials.gov, this trial is currently looking for participants and has been since April 1st 2019. As of October 28th 2022, 90 patients need to be recruited from a single centre in order for it to continue."
To what kind of participants is this research initiative suited?
"This medical trial is searching for 90 people, aged 18 to 60 and with current transcranial direct current stimulation. Participants must also abide by the following conditions: possess an IQ between 70-115; demonstrate informed consent capability; have no severe or persistent mental illness (SPMI) nor addictive disorder as evaluated via MINI International Neuropsychiatric Interview; attend three 45 minute training sessions over 12 weeks and participate in four assessments."
Are there any enrollment opportunities for individuals at this stage of the experiment?
"Affirmative. The information found on clinicaltrials.gov conveys that the medical trial, which was initially posted in April 2019, is actively searching for participants. Approximately 90 individuals must be enrolled at one site to complete the study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Minnesota: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger